skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Multifunctional Protocells for Enhanced Penetration in 3D Extracellular Tumoral Matrices

Journal Article · · Chemistry of Materials
 [1]; ORCiD logo [1];  [2];  [2];  [3];  [2]; ORCiD logo [4];  [1]
  1. Univ. Complutense Madrid (Spain); Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid (Spain)
  2. Univ. of New Mexico, Albuquerque, NM (United States)
  3. Sandia National Lab. (SNL-NM), Albuquerque, NM (United States); Univ. of New Mexico, Albuquerque, NM (United States)
  4. Univ. of New Mexico, Albuquerque, NM (United States); Sandia National Lab. (SNL-NM), Albuquerque, NM (United States)

The high density of the extracellular matrix in solid tumors is an important obstacle to nanocarriers for reaching deep tumor regions and has severely limited the efficacy of administrated nanotherapeutics. The use of proteolytic enzymes prior to nanoparticle administration or directly attached to the nanocarrier surface has been proposed to enhance their penetration, but the low in vivo stability of these macromolecules compromises their efficacy and strongly limits their application. Herein, we have designed a multifunctional nanocarrier able to transport cytotoxic drugs to deep areas of solid tumors and once there, to be engulfed by tumoral cells causing their destruction. This system is based on mesoporous silica nanocarriers encapsulated within supported lipid bilayers (SLBs). The SLB avoids premature release of the housed drug while providing high colloidal stability and an easy to functionalize surface. The tumor penetration property is provided by attachment of engineered polymeric nanocapsules that transport and controllably unveil and release the proteolytic enzymes that in turn digest the extracellular matrix, facilitating the nanocarrier diffusion through the matrix. Additionally, targeting properties were endowed by conjugating an antibody specific to the investigated tumoral cells to enhance binding, internalization, and drug delivery. This multifunctional design improves the therapeutic efficacy of the transported drug as a consequence of its more homogeneous distribution throughout the tumoral tissue.

Research Organization:
Sandia National Lab. (SNL-NM), Albuquerque, NM (United States)
Sponsoring Organization:
USDOE National Nuclear Security Administration (NNSA)
Grant/Contract Number:
AC04-94AL85000
OSTI ID:
1469638
Report Number(s):
SAND2018-9208J; 667256
Journal Information:
Chemistry of Materials, Vol. 30, Issue 1; ISSN 0897-4756
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 46 works
Citation information provided by
Web of Science

References (32)

Cancer statistics, 2016: Cancer Statistics, 2016 journal January 2016
Hallmarks of Cancer: The Next Generation journal March 2011
Cancer targeted therapeutics: From molecules to drug delivery vehicles journal December 2015
Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity journal August 2015
Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies journal January 2015
Stimuli-responsive nanocarriers for drug delivery journal October 2013
PEGylated Inorganic Nanoparticles journal January 2011
Cancer nanomedicine: from targeted delivery to combination therapy journal April 2015
Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds journal January 2014
Analysis of nanoparticle delivery to tumours journal April 2016
“Targeting” nanoparticles: The constraints of physical laws and physical barriers journal December 2012
Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vector journal March 2006
Bromelain Surface Modification Increases the Diffusion of Silica Nanoparticles in the Tumor Extracellular Matrix journal September 2014
Hybrid Collagenase Nanocapsules for Enhanced Nanocarrier Penetration in Tumoral Tissues journal October 2015
Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics journal November 2015
Mesoporous Silica Nanoparticle-Supported Lipid Bilayers (Protocells) for Active Targeting and Delivery to Individual Leukemia Cells journal July 2016
Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery journal January 2016
Delivery of Small Interfering RNA by Peptide-Targeted Mesoporous Silica Nanoparticle-Supported Lipid Bilayers journal February 2012
A New Property of MCM-41:  Drug Delivery System journal February 2001
Mesoporous Materials for Drug Delivery journal October 2007
Analysis of anticancer drugs: A review journal October 2011
Impacts of Mesoporous Silica Nanoparticle Size, Pore Ordering, and Pore Integrity on Hemolytic Activity journal April 2010
The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses journal February 2010
Liposomes as nanomedical devices journal February 2015
Transmission Electron Microscopy of Lipid Vesicles for Drug Delivery: Comparison between Positive and Negative Staining journal June 2010
Hybrid Enzyme-Polymeric Capsules/Mesoporous Silica Nanodevice for In Situ Cytotoxic Agent Generation journal April 2014
Improving catalase-based propelled motor endurance by enzyme encapsulation journal January 2014
Epidermal growth factor receptors in lung tumours journal August 1987
Target-specific near-IR induced drug release and photothermal therapy with accumulated Au/Ag hollow nanoshells on pulmonary cancer cell membranes journal March 2015
Working Together: The Combined Application of a Magnetic Field and Penetratin for the Delivery of Magnetic Nanoparticles to Cells in 3D journal September 2011
Clinical Pharmacokinetics of Topotecan journal January 1996
Development of a highly stable and targetable nanoliposomal formulation of topotecan journal January 2010

Cited By (7)

Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights journal December 2017
Targeting strategies for improving the efficacy of nanomedicine in oncology journal January 2019
Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update journal April 2019
Mesoporous Silica Nanoparticles for the Treatment of Complex Bone Diseases: Bone Cancer, Bone Infection and Osteoporosis journal January 2020
Dendrimer nanoparticles for colorectal cancer applications journal January 2020
Nanomaterials as Promising Alternative in the Infection Treatment journal August 2019
Nanoparticles to Knockdown Osteoporosis-Related Gene and Promote Osteogenic Marker Expression for Osteoporosis Treatment journal May 2019

Figures / Tables (6)